Atricure Inc. Stock
Price
Target price
€33.20
€33.20
7.790%
2.4
7.790%
€46.57
05.12.25 / Frankfurt
WKN: A0ES9W / Symbol: ATRC / Name: AtriCure / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Atricure Inc. Stock
Atricure Inc. dominated the market today, gaining €2.40 (7.790%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Atricure Inc..
As a result the target price of 46 € shows a positive potential of 38.55% compared to the current price of 33.2 € for Atricure Inc..
Pros and Cons of Atricure Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atricure Inc. | 7.790% | 7.792% | 22.963% | -46.452% | -46.452% | -46.452% | -11.702% |
| SI-BONE Inc | 3.680% | 1.198% | 30.000% | 35.200% | 30.000% | - | - |
| Orasure Tech | -2.750% | 3.922% | 2.913% | -40.782% | -38.012% | -55.649% | -80.187% |
| Lantheus Holdings Inc | 1.950% | 4.771% | 20.253% | -36.933% | -39.074% | 2.192% | - |
Comments
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $51.00 to $44.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
News
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
Sven Wehrwein, a member of the Board of Directors at AtriCure (NASDAQ:ATRC), exercised 10,000 non-qualified stock options and immediately sold the underlying shares in derivative transactions on
AtriCure (ATRC) Q2 Revenue Jumps 17%
AtriCure (NASDAQ:ATRC), a medical device company specializing in cardiac surgical technologies, delivered its earnings release on July 29, 2025, reporting results that outpaced Wall Street consensus